Literature DB >> 7617531

Analysis of tissue distribution of valproate in guinea-pigs: evidence for its capacity-limited tissue distribution.

H Y Yu1, Y Z Shen.   

Abstract

The tissue distribution of valproic acid (VPA) was investigated over a wide range of steady-state plasma levels (Css) in guinea-pigs. The VPA concentrations in various tissues, except the kidney, were all lower than in plasma. Tissue-to-unbound plasma concentration ratios (Kpu) of VPA for adipose, heart, kidney, liver, lung, muscle, pancreas and skin all decreased significantly with increasing unbound plasma concentration (Cuss). The Kpu for brain (0.5-0.9), intestine, spleen and stomach failed to show significant change with Cuss. The disposition of VPA in tissues is adequately described by a model in which VPA was distributed in interstitial and intracellular fluid and bound to interstitial albumin, with limited tissue binding. Tissue binding was extensive only in the kidney. Most of the measured apparent Kpu values agreed well with simulated Kpu values. Steady-state tissue concentration of VPA can be predicted from Css and Cuss when reference data for interstitial albumin and tissue total water are available.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617531     DOI: 10.1023/a:1016264821127

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Effect of pregnancy on tissue distribution of salicylate in rats.

Authors:  T Yoshikawa; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  Drug Metab Dispos       Date:  1984 Jul-Aug       Impact factor: 3.922

2.  Pharmacokinetics of valproic acid in guinea-pigs with biliary abnormality.

Authors:  H Y Yu; Y Z Shen
Journal:  J Pharm Pharmacol       Date:  1991-07       Impact factor: 3.765

3.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

4.  Concepts basic to pharmacokinetics.

Authors:  T N Tozer
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

5.  Phenobarbitone effects on hepatic microsomal enzymes and liver blood flow in the guinea pig.

Authors:  M S Yates; C R Hiley; M R Challiner; B K Park
Journal:  Biochem Pharmacol       Date:  1979-09-15       Impact factor: 5.858

6.  Immunological studies of Y protein. A major cytoplasmic organic anion-binding protein in rat liver.

Authors:  G Fleischner; J Robbins; I M Arias
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

7.  Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions.

Authors:  G Litwack; B Ketterer; I M Arias
Journal:  Nature       Date:  1971-12-24       Impact factor: 49.962

8.  Dose-dependent inhibition in plasma protein binding of valproic acid during continued treatment in guinea-pigs.

Authors:  H Y Yu; Y Z Shen
Journal:  J Pharm Pharmacol       Date:  1992-05       Impact factor: 3.765

9.  Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.

Authors:  A Tsuji; T Yoshikawa; K Nishide; H Minami; M Kimura; E Nakashima; T Terasaki; E Miyamoto; C H Nightingale; T Yamana
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

10.  Dose-dependent pharmacokinetics of valproate in guinea pigs of different ages.

Authors:  H Y Yu; Y Z Shen; Y Sugiyama; M Hanano
Journal:  Epilepsia       Date:  1987 Nov-Dec       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.